The Food Effect on the Pharmacokinetics of NVP-1402
Phase of Trial: Phase I
Latest Information Update: 25 May 2018
At a glance
- Drugs NVP 1402 (Primary)
- Indications CNS disorders
- Focus Pharmacokinetics
- Sponsors Navipharm
- 16 May 2018 Status changed from active, no longer recruiting to completed.
- 06 Mar 2018 Planned End Date changed from 28 Feb 2018 to 30 Apr 2018.
- 20 Dec 2017 Status changed from not yet recruiting to active, no longer recruiting.